Highlights

  • Doctor Care Anywhere reported its first full-year profit in 2025.
  • FY25 Revenue reached £38.0 million, with underlying EBITDA of £5.3 million.
  • The company is scheduled to release H1 FY26 results on 17 August 2026.
  • Doctor Care Anywhere reported approximately 1.28 million activated lives on its platform by the end of 2025.

Doctor Care Anywhere (ASX:DOC) is a United Kingdom-based digital healthcare company providing virtual consultations with general practitioners and specialists through video and phone services. The company is focused on scaling its business-to-business healthcare platform while maintaining profitability following its first annual profit.

At the time of writing on 14 August 2026, Doctor Care Anywhere (ASX:DOC) was trading at AUD 0.12, up 4.55% on the day.

The company is approaching its H1 FY26 results announcement, which will provide further insight into whether its profitability improvement has continued during 2026.

What Just Happened?

On 31 July 2026, Doctor Care Anywhere announced changes to its finance Leadership ahead of its half-year results. Interim chief financial officer Niall Dore stepped down, with chief executive Laura O’Riordan covering the role from 1 August until a permanent appointment.

Lisa Barter was appointed interim CFO, commencing on 18 August 2026. The company stated that Barter brings more than 25 years of healthcare finance experience.

Doctor Care Anywhere also confirmed that its H1 FY26 results for the six months ended 30 June 2026 would be released on 17 August 2026.

The upcoming results follow FY25 performance, where the company reported revenue of £38.0 million, underlying Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) of £5.3 million and net profit of £1.2 million.

Why It Matters

Doctor Care Anywhere’s transition from losses to profitability has changed the focus of the business. The company is now being assessed on its ability to maintain earnings growth and expand margins rather than simply increasing platform usage.

FY25 underlying EBITDA improved significantly compared with the prior year, while the contribution Margin increased to 43.5%. The company also generated £2.2 million in cash during the year and ended FY25 with £6.6 million in cash.

The H1 FY26 results will provide an important measure of whether these improvements can continue.

Maintaining revenue growth, controlling costs and increasing healthcare platform utilisation will remain key factors in assessing the company’s progress.

The Bigger Picture

Doctor Care Anywhere operates a digital-first healthcare platform in the United Kingdom, connecting patients with clinicians for remote consultations, prescriptions, referrals and follow-up care.

The company primarily operates through contracts with private health insurers and corporate health providers, giving members access to virtual healthcare services.

By the end of 2025, Doctor Care Anywhere reported approximately 1,275,700 activated lives on its platform, representing growth of 7.9% YoY. The company delivered approximately 683,500 consultations during the year.

Total consultation volumes declined approximately 4.0% during 2025, partly due to the closure of a secondary care pathway, although second-half consultation volumes increased 3.4%.

Management has outlined a medium-term ambition to approximately double revenue over three to five years while maintaining an EBITDA margin of around 15%.

What Could Drive the Shares Next?

The H1 FY26 results on 17 August 2026 represent the next major milestone for Doctor Care Anywhere.

Investors will monitor revenue growth, EBITDA margin performance, activated lives, consultation volumes and evidence that the company’s profitability improvement has continued.

Further clarity around finance leadership following the interim CFO transition may also be relevant.

Longer term, expanded insurer and employer partnerships, continued cash generation and progress toward the company’s medium-term growth targets may influence future expectations.

The company also has access to a £10.6 million convertible Loan facility, with repayments not required until 31 December 2027, providing additional financial flexibility.

Risks Investors Should Watch

Doctor Care Anywhere faces risks related to customer concentration, competition, regulation and execution. The company relies on a relatively small number of large insurer and corporate contracts, meaning changes to key partnerships could affect revenue. Consultation volumes and service mix can also change depending on healthcare pathways. Executive transitions may create uncertainty, particularly around financial reporting periods. The digital healthcare sector remains competitive and regulated, while profitability is still developing. Additional risks include currency exposure between UK operations and Australian-listed shares, as well as liquidity risks associated with smaller ASX-listed companies.

Bottom Line

Doctor Care Anywhere (ASX:DOC) enters its H1 FY26 results period after achieving its first annual profit, improving margins and expanding its digital healthcare platform.

The company’s FY25 performance demonstrated progress toward a more sustainable operating model, supported by revenue growth, higher EBITDA and cash generation.

The upcoming half-year results will determine whether the profitability improvement has continued and whether the company remains on track with its medium-term growth strategy.

While the Business has improved its financial position, future performance will depend on maintaining major healthcare partnerships, expanding platform usage and sustaining profitability.